REQUEST A DEMO
Total
USD $0.00
Search more companies

Abnova (Taiwan) Corporation (亚诺法生技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Abnova (Taiwan) Corporation Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Abnova (Taiwan) Corporation is a company specializing in the production of antibodies and proteins. They offer products and services, including custom miRNA probe design, laboratory services for investigating circulating tumor DNA, and a platform for quantification of COVID-19 neutralizing antibodies. Abnova also provides a diverse single-clone antibody for research partners and academic institutions. With over 130,000 products in their portfolio, Abnova claims to be a leading container of protein & antibody company.

Headquarters
9F, No.108, Jhouzih St, Neihu
Taipei City; Taipei City;

Contact Details: Purchase the Abnova (Taiwan) Corporation (亚诺法生技股份有限公司) report to view the information.

Website: http://www.abnova.com

Basic Information
Total Employees:
Purchase the Abnova (Taiwan) Corporation (亚诺法生技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Abnova (Taiwan) Corporation (亚诺法生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Abnova (Taiwan) Corporation (亚诺法生技股份有限公司) report to view the information.
Incorporation Date:
January 04, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
6.03%
Purchase this report to view the information.
4.04%
Purchase this report to view the information.
3.71%
Purchase this report to view the information.
3.04%
Purchase this report to view the information.
1.71%
Subsidiaries
Abnova Holding Corporation (United Kingdom)
100%
核心生醫投資股份有限公司
100%
Company Performance
Financial values in the chart are available after Abnova (Taiwan) Corporation (亚诺法生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
0.06%
Total operating revenue
-0.09%
Operating Profit/Loss (EBIT)
-73.89%
EBITDA
-34%
Net Profit/Loss for the Period
N/A
Total Assets
-4.04%
Total Equity
-4.06%
Operating Profit Margin (ROS)
-8.04%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
1.25%
Quick Ratio
0.41%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?